Pfizer and BioNTech Initiate Rolling Submission of Biologics License Application for U.S. FDA Approval of their COVID-19 VaccineGlobeNewsWire • 05/07/21
Covid vaccine makers' shares seesaw after Biden administration says it will back patent waiversCNBC • 05/06/21
Vaccine Stocks Pare Deep Losses As Angela Merkel Opposes Waiving PatentsInvestors Business Daily • 05/06/21
Coronavirus: Moderna says tweaked vaccine works against variants, two BioNTech/Pfizer doses give 95% protectionProactive Investors • 05/06/21
Pfizer and BioNTech to supply IOC with COVID-19 vaccines for Olympic and Paralympic Games athletesMarket Watch • 05/06/21
Canada authorizes Pfizer's COVID-19 vaccine for kids between the ages of 12 and 15 years oldMarket Watch • 05/05/21
This COVID-19 Vaccine Stock Quietly Soared 75% In April: Is There More Upside Ahead?Benzinga • 05/05/21
BioNTech SE Sponsored ADR (BNTX) Stock Jumps 11%: Will It Continue to Soar?Zacks Investment Research • 05/04/21
BioNTech to Report First Quarter 2021 Financial Results and Operational Update on May 10, 2021GlobeNewsWire • 05/04/21
Pfizer COVID-19 Vaccine Expected To Get FDA Emergency Approval For Age Group 12-15 Next WeekBenzinga • 05/04/21
FDA to authorize the use of the Pfizer COVID-19 vaccine for those ages 12-15 as early as next week, The New York Times reportsBusiness Insider • 05/03/21
Pfizer says it submitted application for COVID-19 vaccine to Indian regulators 'months ago'Market Watch • 05/03/21